Stonehage Fleming Financial Services Holdings Ltd Has $174.52 Million Stock Position in Stryker Corporation $SYK

Stonehage Fleming Financial Services Holdings Ltd decreased its position in Stryker Corporation (NYSE:SYK) by 1.1% during the 2nd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 441,106 shares of the medical technology company’s stock after selling 5,106 shares during the period. Stryker comprises approximately 5.1% of Stonehage Fleming Financial Services Holdings Ltd’s portfolio, making the stock its 10th biggest holding. Stonehage Fleming Financial Services Holdings Ltd’s holdings in Stryker were worth $174,515,000 at the end of the most recent reporting period.

Other institutional investors have also bought and sold shares of the company. Sachetta LLC lifted its stake in Stryker by 58.7% in the second quarter. Sachetta LLC now owns 73 shares of the medical technology company’s stock valued at $29,000 after purchasing an additional 27 shares during the last quarter. Goodman Advisory Group LLC purchased a new position in Stryker in the first quarter valued at approximately $32,000. Ridgewood Investments LLC lifted its stake in Stryker by 48.4% in the second quarter. Ridgewood Investments LLC now owns 92 shares of the medical technology company’s stock valued at $36,000 after purchasing an additional 30 shares during the last quarter. Ransom Advisory Ltd purchased a new position in Stryker in the first quarter valued at approximately $37,000. Finally, Smallwood Wealth Investment Management LLC purchased a new position in Stryker in the first quarter valued at approximately $40,000. Hedge funds and other institutional investors own 77.09% of the company’s stock.

Insider Transactions at Stryker

In other Stryker news, insider Viju Menon sold 500 shares of the company’s stock in a transaction dated Monday, August 25th. The stock was sold at an average price of $390.61, for a total value of $195,305.00. Following the transaction, the insider directly owned 12,511 shares in the company, valued at $4,886,921.71. This represents a 3.84% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, Director Ronda E. Stryker sold 200,000 shares of the company’s stock in a transaction dated Wednesday, August 6th. The stock was sold at an average price of $376.45, for a total value of $75,290,000.00. Following the completion of the transaction, the director owned 3,222,108 shares in the company, valued at $1,212,962,556.60. This represents a 5.84% decrease in their ownership of the stock. The disclosure for this sale can be found here. 5.90% of the stock is owned by corporate insiders.

Stryker Stock Performance

NYSE:SYK opened at $364.77 on Friday. The company has a debt-to-equity ratio of 0.70, a quick ratio of 1.06 and a current ratio of 1.78. Stryker Corporation has a 52-week low of $329.16 and a 52-week high of $406.19. The firm has a market cap of $139.46 billion, a price-to-earnings ratio of 48.31, a PEG ratio of 2.63 and a beta of 0.94. The business’s fifty day moving average is $380.25 and its 200 day moving average is $378.83.

Stryker (NYSE:SYK) last announced its earnings results on Thursday, July 31st. The medical technology company reported $3.13 earnings per share for the quarter, topping analysts’ consensus estimates of $3.07 by $0.06. The business had revenue of $6.02 billion for the quarter, compared to analyst estimates of $5.92 billion. Stryker had a return on equity of 23.94% and a net margin of 12.25%.The company’s quarterly revenue was up 11.1% compared to the same quarter last year. During the same period in the prior year, the company earned $2.81 EPS. Stryker has set its FY 2025 guidance at 13.400-13.600 EPS. Research analysts predict that Stryker Corporation will post 13.47 EPS for the current year.

Stryker Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Friday, October 31st. Shareholders of record on Tuesday, September 30th will be paid a $0.84 dividend. This represents a $3.36 dividend on an annualized basis and a yield of 0.9%. The ex-dividend date is Tuesday, September 30th. Stryker’s dividend payout ratio is currently 44.50%.

Wall Street Analyst Weigh In

Several equities analysts recently commented on SYK shares. Wall Street Zen downgraded Stryker from a “buy” rating to a “hold” rating in a research note on Friday, September 26th. Redburn Partners set a $420.00 price objective on Stryker in a research note on Thursday, September 18th. Weiss Ratings reaffirmed a “buy (b-)” rating on shares of Stryker in a report on Wednesday. Evercore ISI reduced their price target on Stryker from $418.00 to $410.00 and set an “outperform” rating for the company in a research report on Tuesday. Finally, Needham & Company LLC boosted their price objective on Stryker from $442.00 to $448.00 and gave the company a “buy” rating in a research note on Friday, August 1st. Fifteen equities research analysts have rated the stock with a Buy rating and six have assigned a Hold rating to the stock. Based on data from MarketBeat.com, Stryker has an average rating of “Moderate Buy” and an average price target of $430.10.

About Stryker

Stryker Corporation operates as a medical technology company. The company operates through two segments, MedSurg and Neurotechnology, and Orthopaedics and Spine. The Orthopaedics and Spine segment provides implants for use in total joint replacements, such as hip, knee and shoulder, and trauma and extremities surgeries.